| SKU: Item |
Format |
Price (USD) |
Complete Conference Online Access / CM-ROM Set - Days 1-3 (Digital Audio with synchronized PowerPoint)
|
|---|
| SET/SETCD/SETCDA/SETON/SETONA/STA: Complete Conference CD-ROM Set - Days 1-3 | Audio CD-ROM PPT Set
Regular Attendee | $195.00 |  |
Audio CD-ROM PPT Set
| $300.00 | |
| Online Offering | $ 195.00 | |
| Online Offering | $ 300.00 | |
Special Educational Online Access / CD-ROM - SHORT COURSES (Digital Audio with synchronized PowerPoint)
|
|---|
| SC/SCA/SCON/SCONA/SCROM/SCROMA: Special Educational CD-ROM (Wednesday, October 3, 2007) - 9 SHORT COURSES | Audio CD-ROM PPT Set
Regular Attendee | $100.00 | |
Audio CD-ROM PPT Set
| $175.00 | |
| Online Offering | $ 100.00 | |
| Online Offering | $ 175.00 | |
Special Online Access / CD-ROMs by Day (Digital Audio with synchronized PowerPoint)
|
|---|
| D1A/DY1/DY1ON/DY1ONA/DY1ROM/DY1ROMA: Day 1 - Thursday, October 4, 2007 | Audio CD-ROM PPT Set
Regular Attendee | $95.00 | |
Audio CD-ROM PPT Set
| $150.00 | |
| Online Offering | $ 95.00 | |
| Online Offering | $ 150.00 | |
| D2A/DY2/DY2ON/DY2ONA/DY2ROM/DY2ROMA: Day 2 - Friday, October 5, 2007 | Audio CD-ROM PPT Set
Regular Attendee | $95.00 | |
Audio CD-ROM PPT Set
| $150.00 | |
| Online Offering | $ 95.00 | |
| Online Offering | $ 150.00 | |
| D3A/DY3/DY3ON/DY3ONA/DY3ROM/DY3ROMA: Day 3 - Saturday, October 6, 2007 | Audio CD-ROM PPT Set
Regular Attendee | $95.00 | |
Audio CD-ROM PPT Set
| $150.00 | |
| Online Offering | $ 95.00 | |
| Online Offering | $ 150.00 | |
P1/P1A: From Basic Science to the Clinic: Where Are We & What Is Still Missing
Margarida D. Amaral, Preston W. Campbell, III, Cam C. McLoud, Robert J. Beall | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
P1-0/P1-0A: Welcome & Introductions
Preston W. Campbell, III, Cam C. McLoud, Robert J. Beall | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
P1-1/P1-1A: Plenary Session I: "From Basic Science to the Clinic: Where Are We & What Is Still Missing?"
Margarida D. Amaral | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S1/S1A: CFTR Structure: Putting It All Together | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S1-0/S1-0A: Introduction
Diana R. Wetmore | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S1-1/S1-1A: CFTR Structure: What We Can Learn from Electron Microscopy
Robert Ford | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S1-2/S1-2A: Structure of the Human CFTR NBD1 Domain as a Homodimer: Insights and Applications
Shane Atwell | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S1-3/S1-3A: Novel Approaches for Expression, Stabilization and Crystallization of CFTR
Larry DeLucas | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S1-4/S1-4A: Modeling Full Length CFTR: From Sequence to Structure
Hanoch Senderowitz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S2/S2A: Is It All Genetics? | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S2-0/S2-0A: Introduction
Garry R. Cutting | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S2-1/S2-1A: Non-genetic Influences on CF Disease Severity
Michael S. Schechter | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S2-2/S2-2A: Air Pollution As a Modifier of Lung Function
Christopher H. Goss | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S2-3/S2-3A: Gene-environment Interactions in Susceptibility to Tuberculosis Disease
Erwin Schurr | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S2-4/S2-4A: Interactions Among Environmental and Genetic Factors that Affect CF Lung Disease Severity
J. Michael Collaco | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S3/S3A: Physics of Mucus Transport | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S3-0/S3-0A: Introduction
Richard Superfine | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S3-1/S3-1A: Rheology and Optimization of Adhesive Locomotion
Anette Hosoi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S3-2/S3-2A: Computational Model of Mucociliary Clearance - Relevance to Therapy
Sorin Mitran | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S3-3/S3-3A: Polymer Physics of the Periciliary Layer
John Sheehan, Michael Rubinstein | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S3-4/S3-4A: Mucociliary Clearance: Physics to Physiology
Brian Button | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S4/S4A: Pros and Cons: Gastrostomy Tubes in Patients with CF and Acid Suppression Improves PERT Function | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S4-0: Introduction
Maria Mascarenhas | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S4-1/S4-1A: We Do Not Need to Use Gastrostomy Tubes (GT) to Improve Outcomes in Patients with CF
Scott W. Powers | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S4-2/S4-2A: We Need to Use Gastrostomy Tubes to Improve Outcomes in Patients with CF
Jamie Erskine | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S4-3/S4-3A: Acid Suppression Improves Effectiveness of Pancreatic Enzyme Replacement Therapy
Jacqueline L. Fridge | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S4-4/S4-4A: Use of Acid Suppressive Agents Should Not be a Standard Part of CF Care
Daina B. Kalnins | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S5/S5A: Identification of Novel Therapeutic Targets in the Post-genomic Era | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S5-0: Introduction
Alice Prince | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S5-1/S5-1A: The Response of Bronchial Epithelial Cells to Pseudomonas aeruginosa: Beyond Gene Expression Profiling
Pieter S. Hiemstra | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S5-2/S5-2A: Therapeutic Targets Defined by Pseudomonas aeruginosa Adaptation to the CF Airway
Samuel I. Miller | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S5-3/S5-3A: Are Pulmonary Phospholipids and Fatty Acids Attractants or Foods for Pseudomonas aeruginosa?
Michael L. Vasil | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S5-4/S5-4A: Neuraminidase Inhibitors to Prevent P. aeruginosa Infection
Alice Prince | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S6/S6A: Pain Management in the Cystic Fibrosis Patient | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S6-0/S6-0A: Introduction
Susan R. Osmond | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S6-1-2/S6-1-2A: Pain Management in the Cystic Fibrosis Patient: The Spectrum of Pain in the Hospitalized Patient with CF
Miles Belgrade, Chris Peltier | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S6-3: Case Studies Panel Discussion
Miriam Kaufman, Susan R. Osmond, Miles Belgrade, Chris Peltier | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S6-4/S6-4A: A Developmental Approach to Adolescent Pain
Miriam Kaufman | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S7/S7A: Controversial Issues in Aerosol Therapy | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S7-0/S7-0A: Introduction
Allan L. Coates | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S7-1/S7-1A: Introduction to Aerosol Science
Martin Knoch | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S7-2A/S7-2AA: The Combination of Drug & Device Used for Respiratory Medications Should Be FDA Approved: Pro
David E. Geller | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S7-2B/S7-2BA: The Combination of Drug & Device Used for Respiratory Medications Should Be FDA Approved: Con
Allan L. Coates | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S7-3/S7-3A: Cleaning Controversies
David A. Blackney, Catherine O'Malley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W1/W1A: Modifier Genes | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W10/W10A: Making the CF Diagnosis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-0/W1-0A: Introduction
Julian Zielenski | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-0/W10-0A: Introduction
Peter R. Durie | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-1/W10-1A: Use and Interpretation of CFTR Mutation Analysis in the Clinical Setting: An International Consensus
Carlo Castellani | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-2/W10-2A: CF Foundation Consensus on CF Diagnosis
Philip Farrell | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-3/W10-3A: Redefining the Diagnostic Parameters for Cystic Fibrosis
Annie Dupuis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-4/W10-4A: Abstract 185. The Reference Range for Sweat Chloride Testing and Genotype Analysis for Newborns Who Are Heterozygote Carriers of Cystic Fibrosis
Zafer Soultan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-5/W10-5A: Abstract 187. CFTR Screening Does Not Identify All CFTR Coding Region Mutations in CF Patients
Molly Sheridan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-6/W10-6A: Abstract 188. Diagnosing Cystic Fibrosis in Adults: Is Sweat Testing Still the Gold Standard?
Elinor Langfelder-Schwind | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W10-7/W10-7A: Discussion & Wrap-up
Carlo Castellani | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-1/W1-1A: Abstract 179. Variants in the Endothelin Receptor A Gene Associate with Increased Expression Levels, Increased Cell Proliferation, and More Severe Pulmonary Disease in CF Females
Mitchell L. Drumm | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-2/W1-2A: Abstract 180. The Beta-Defensin Repeat Region Affects Cystic Fibrosis Lung Disease Severity
Hilde M. Nuytten | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-3/W1-3A: Abstract 181. A 6 Megabase Region on the Long Arm of Chromosome 5 Displays Linkage to Cross-sectional and Longitudinal Measures of Cystic Fibrosis Lung Disease Severity
Lori L. Vanscoy | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-4/W1-4A: Abstract 182. TCF7L2, a Risk Gene for Type 2 Diabetes, Is Associated with Cystic Fibrosis-related Diabetes
Scott M. Blackman | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-5/W1-5A: Abstract 183. Assessing Mucin Gene Polymorphisms to Determine Their Role As Modifiers of Different CF Phenotypes
Xueliang Guo | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-6/W1-6A: Abstract 184. Assessment of Genetic Modifiers for Phenotypic Severity of Beta-ENaC Transgenic Mice
Wanda O'Neal | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W1-7/W1-7A: Discussion & Wrap-up
Samuel M. Moskowitz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W2/W2A: CFTR 2007 | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W2-1/W2-1A: Abstract 1. Processing and Function of CFTR-Î"F508 Are Species Dependent
Lynda S. Ostedgaard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W2-2/W2-2A: Abstract 2. Differences in Interactions of WT and Î"F508 NBD1 with Other Regions of CFTR
Voula Kanelis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W2-3/W2-3A: Abstract 3. SHSPS Target Î"F508 CFTR for ERAD via the Sumo Pathway
Raymond A. Frizzell | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W2-4/W2-4A: Abstract 4. Dynasore Prevents CFTR Removal From the Cell Surface
Andrew Young | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W2-5/W2-5A: Abstract 5. Identification of a Non-native State of NBD1 that Is Affected by Î"F508
John M. Richardson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W2-6/W2-6A: Abstract 6. CAL-dependent Degradation of CFTR by Trans-golgi Network Localized Snare Protein Syntaxin-6
Jie Cheng | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W2-7/W2-7A: Discussion & Wrap-up
Fred van Goor | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W3/W3A: Pushing the Envelope: New Concepts in CF Therapy | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-0/W3-0A: Introduction
Eric Alton | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-1/W3-1A: Abstract 239. Repeated Administration of Lentiviral Vector to Mouse Nasal Epithelia Enhances Expression without Emergence of Blocking Mucosal Immune Responses
Patrick L. Sinn | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-2/W3-2A: Abstract 240. Bronchoscope-guided, Targeted Lobar Aerosolization of HDAD into Nonhuman Primate Lungs Results in Uniform, High Level Pulmonary Transduction, Long Term Transgene Expression and Negligible Toxicity
Peter W. Hiatt | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-3/W3-3A: Abstract 241. Airway Stem/Progenitor Cell Integration
Uta Griesenbach | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-4/W3-4A: The Path to the Clinic for VX-770, a Novel CFTR Potentiator
Eric Olson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-5/W3-5A: Abstract 242. High Throughput Screening Assay for Airway Mucin Secretion
Nancy McNamara | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-6/W3-6A: CF - HCO3- = Mucoviscidosis
Paul M. Quinton | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W3-7/W3-7A: Discussion & Wrap-up
Eric Alton | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W4/W4A: CF Airway Defense and Redox State | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-0/W4-0A: CF Airway Defense & Redox State: Introduction
Horst Fischer | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-1/W4-1A: Abstract 143. Regulation of the LPO Antibacterial System Through Hydrogen Peroxide Production
Gregory E. Conner | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-2/W4-2A: DUOX1 in the Airway Epithelium: Role in Epithelial Repair and Remodeling
Albert van der Vliet | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-3/W4-3A: Abstract 144. Neutrophil Defects in Cystic Fibrosis
Guoshun Wang | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-4/W4-4A: Abstract 146. Dual Effects of Pyocyanin-induced Oxidative Stress on CFTR Chloride Transport
Beate Illek | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-5/W4-5A: Abstract 147. A Role of Glutathione Transport in the Attenuation of Oxidative Injury by Hypertonic Saline
Brian J. Day | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-6/W4-6A: NO Plus
Benjamin Gaston | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W4-7/W4-7A: Discussion & Wrap-up
Hartmut Grasemann | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W5/W5A: Infectious Diseases Management | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-0/W5-0A: Introduction
Scott H. Donaldson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-1/W5-1A: Abstract 305. Bacterial Microfloral Diversity of the Cystic Fibrosis Lung by 16S Ribosomal RNA
David Hwang | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-2/W5-2A: Abstract 306. Antibiotic Susceptibility of Anaerobic Bacteria Cultured from the Sputum of Cystic Fibrosis Patients Grown Planktonically and as Biofilms
T.R. Field | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-3/W5-3A: Abstract 307. "Time to Event" Analysis of Efficacy of an Early Aggressive Eradication Protocol for First Growth Pseudomonas aeruginosa in Cystic Fibrosis
A. George F. Davidson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-4/W5-4A: Abstract 308. Phase 3 Trial (AIR-CF 1) Measuring Improvement in Respiratory Symptoms in Patients with Cystic Fibrosis Following Treatment with Aztreonam Lysine for Inhalation (AZLI)
George Z. Retsch-Bogart | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-5/W5-5A: Abstract 309. A Comparison of Oral Chloramphenicol and Oral Ciprofloxacin in the Treatment of Pseudomonas aeruginosa Infections in Patients with Cystic Fibrosis
Christopher Orchard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-6/W5-6A: Abstract 310. Sustained Effect of Prophylactic Treatment with IgY Against P. aeruginosa Infections
Elin Nilsson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W5-7/W5-7A: Discussion & Wrap-up
Elizabeth Tullis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W6/W6A: Adult Issues in CF | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-0/W6-0A: Introduction
Suzanne Cumming | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-1/W6-1A: Testosterone Replacement in Males with CF
Marcia Katz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-2/W6-2A: Abstract 544. Self-reported Treatment Burden in Adults with Cystic Fibrosis
Gregory Sawicki | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-3/W6-3A: Abstract 545. The Estimated Incidence of Patients with Cystic Fibrosis Having a CF Affected Child: A Survey of Centers Throughout the United States
Paula H. Lomas | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-4/W6-4A: Abstract 546. Why Do So Few Men with Cystic Fibrosis Seek Fertility Treatment?
Alan Anderson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-5/W6-5A: Abstract 547. Cardiac Dysfunction in Adult CF Patients with Severe Lung Disease - A Retrospective CoHort Study
Edward Nash | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-6/W6-6A: CF Transition Care...an Adult Issue Also?
Suzanne Cumming, Anna M. Gravelle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W6-7/W6-7A: Discussion & Wrap-up
Anna M. Gravelle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W7/W7A: Medical & Psychosocial Challenges & Solutions to G-tube Placement Throughout the Lifecycle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-0/W7-0A: Introduction
Joyce J. Bagyi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-1/W7-1A: Abstract 484. Impact of Improved Nutritional Status with Gastrostomy Feedings on Pulmonary Exacerbations in Cystic Fibrosis
Judy Galvez | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-2/W7-2A: Diagnosis & Dialogue: The Role of the Physician in the Tube Feeding Decision
Susanna McColley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-3/W7-3A: Family Centered Approach to the Initiation of Gastrostomy Tube Feedings
Nan Ransom | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-4/W7-4A: Abstract 485. Percutaneous Endoscopic Gastrostomy (PEG) In Cystic Fibrosis: Effects on Nutrition and Pulmonary Function
Kyle M. Jensen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-5/W7-5A: Challenges to Gastrostomy Tube Placement in Adolescent with Cystic Fibrosis
Kimberly Scott | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-6/W7-6A: Adults with Advanced Lung Disease and Gastrostomy Tube Placement
Joyce Bagyi, John P. Nash | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W7-7/W7-7A: Discussion & Wrap-up
Joyce J. Bagyi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W8/W8A: Assessment and Treatment of Depression in Pediatric and Adult Patients with CF | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-0/W8-0A: Introduction
Alexandra L. Quittner | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-1/W8-1A: Abstract 548. Emotional Distress in Parents of Infants with CFTR-related Disorders Diagnosed Through Neonatal Screening
Sandra Perobelli | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-2/W8-2A: Preliminary Results of the National Depression and Anxiety Screening Study in Two CF Centers in Ohio
Avani C. Modi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-3/W8-3A: Evidence-based Treatment for Adolescents with Depression
Lutz Goldbeck | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-4/W8-4A: Abstract 549. Physical Health and Anxiety Symptoms: Does Monitoring Mediate the Relationship?
David Bennett | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-5/W8-5A: Comorbidity of Depression and Cystic Fibrosis in Children and Adolescents: Associations with Medical Adherence
Beth Smith | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-6/W8-6A: Levels of Depression and Anxiety in Hispanic Patients with CF and Their Caregivers
Kristen Marciel | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W8-7/W8-7A: Discussion & Wrap-up
Alexandra L. Quittner | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W9/W9A: Time for Airway Clearance | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W9-0/W9-0A: Introduction
Adrienne Prestridge | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W9-1/W9-1A: Exercise and Airway Clearance
Tiffany Dwyer | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W9-2/W9-2A: Abstract 431. Measuring Patient Compliance in Inhalation Studies by Smart Card Technology
Axel Fischer | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W9-3/W9-3A: Strategies to Reduce Time for Airway Clearance
Mark R. Elkins | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W9-4/W9-4A: Abstract 432. Delivery of Hypertonic Saline from an Adaptive Aerosol Delivery Nebulizer and a Conventional Jet Nebulizer
Katja Williams | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W9-5/W9-5A: Abstract 434. Aerosolization of Liposomal Amikacin (ArikaceTM) Using Different Nebulizers: Selection of the eFlow
Walter R. Perkins | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W9-6/W9-6A: Abstract 435. Methodologies for Targeting Aerosolized Drugs to the Conducting Airways
Kirby Zeman | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W9-7/W9-7A: Discussion & Wrap-up | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
P2/P2A: CF Drug Development: What's New?
Felix Ratjen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
P2-0/P2-0A: Plenary Session II: "CF Drug Development: What's New?"
Felix Ratjen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S10/S10A: Mucosal Pathogen Interaction | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S10-0/S10-0A: Introduction
Gunnar C. Hansson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S10-1/S10-1A: Mucin Structure and Its Function As the Main Trap for Microbes
Gunnar C. Hansson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S10-2/S10-2A: Small Intestinal Bacterial Overgrowth in the CF Mouse: Roles of Mucus and Motility
Robert de Lisle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S10-3/S10-3A: Microbial Community Assembly and Host-microbial Interactions in the Intestine
John F. Rawls | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S10-4/S10-4A: When Pathogen Meets Host-Clues for Development of Novel Therapeutics
Peter Greenberg | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S11/S11A: Airway Defenses : New Developments in Host-Pathogen Interactions | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S11-0/S11-0A: Introduction
Paul B. McCray, Jr. | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S11-1/S11-1A: Hit Them Where They Eat: Antimicrobial Strategies that Target Bacterial Metabolism
Dao Nguyen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S11-2/S11-2A: Polymicrobial Interactions in CF: Synergies and Antagonisms in Host Response
Michael G. Surette | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S11-3/S11-3A: Role of CFTR in the Regulation of Intracellular Acidification and Bacterial Killing in Alveolar Macrophages
Deborah J. Nelson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S11-4/S11-4A: An Oxidant Driven Microbicidal System in Airway Epithelia
Botond Banfi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S12/S12A: Medical, Neurocognitive, and Psychosocial Effects of Sleep Problems in CF | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S12-0/S12-0A: Introduction
Alexandra L. Quittner | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S12-1/S12-1A: An Overview of Sleep in the CF Literature
Nanci Yuan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S12-2/S12-2A: Sleep Disturbance and Pulmonary Function in CF Patients
Raouf Amin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S12-3/S12-3A: Sleep in CF - Is It Broken?
Manu Jain | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S12-4/S12-4A: Sleep Disordered Breathing in CF and Effects of Treatment
Peter T.P. Bye | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S13/S13A: Pulmonary and Nutritional Care of the Young Child with CF | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S13-0/S13-0A: Introduction
Michelle S. Howenstine | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S13-1/S13-1A: Nutritional Issues in Diagnosis and Management of Infants and Young Children with CF
Drucy Borowitz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S13-2/S13-2A: Breathing Lessons: How Can We Keep the Pre-school Lung Healthy?
Brian O'Sullivan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S13-3/S13-3A: Using Diagnostic Tools in the Young Child: X-rays and Pulmonary Function Tests
Stephanie D. Davis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S13-4/S13-4A: Guiding Parents on the CF Journey
Mary M. Kontos, Jenny Drapeau | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S14/S14A: Update on Quality Improvement and Benchmarking | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S14-0/S14-0A: Introduction
Michael S. Schechter | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S14-1/S14-1A: The Adult CF Benchmarking Project: What Have We Learned?
Christine M. Singh, Michael P. Boyle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S14-2/S14-2A: CF Quality Improvement: Effect on Outcomes
Michael S. Schechter | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S14-3/S14-3A: Improving CF Outcomes at Children's Memorial Hospital: A Case Study
Stacy L. VandenBranden, Susanna McColley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S14-4/S14-4A: The CF Foundation Quality Improvement Initiative: Lessons Learned and Future Directions
Bruce C. Marshall | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S8/S8A: CFTR: Biogenesis and Post-ER Quality Control | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S8-0/S8-0A: Introduction
Gergely L. Lukacs | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S8-1/S8-1A: Cotranslational Folding of Ribosome-bound Nascent CFTR Polypeptides
William R. Skach | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S8-2/S8-2A: Reconstitution and the Identification of New Factors Required for CFTR/Ste6p* Quality Control in the Endoplasmic Reticulum
Jeffery L. Brodsky | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S8-3/S8-3A: Membrane/Cytoplasmic Domain Contacts in CFTR
John R. Riordan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S8-4/S8-4A: ESCRTs in Membrane Trafficking and Quality Control
Fei Sun, Gergely L. Lukacs | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S9/S9A: CF Liver Disease: From the Bench to the Bedside | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S9-0/S9-0A: Introduction | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S9-1/S9-1A: Pathophysiology of CF-associated Liver Disease: Lessons from the Bench
Michael R. Narkewicz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S9-2/S9-2A: Biomarkers and Non-invasive Imaging for CF associated Liver Disease: Search for the Holy Grail
Michael R. Narkewicz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S9-3/S9-3A: Natural History of CF-associated Liver Disease
Carla Colombo | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S9-4/S9-4A: Treatment Options for CF-associated Liver Disease
Saul Karpen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W11/W11A: Pulmonary Guidelines & Care | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-0/W11-0A: Introduction
Patrick A. Flume | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-1/W11-1A: Abstract 368. Large U.S. Cohort of Young Pseudomonas-negative CF Patients: Mild Lung Disease, Heterogeneous Management
Margaret Rosenfeld | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-2/W11-2A: Abstract 369. Lung Function Is Diminished in Infants with CF Diagnosed by Newborn Screening Regardless of Pulmonary Infection Detected in Broncho-alveolar Lavage
Sarath C. Ranganathan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-3/W11-3A: Abstract 370. Comparison of Antibiotics for Early Pseudomonas Infection in CF: Interim Data Analysis
Terry L. Noah | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-4/W11-4A: Abstract 371. Improvements in Lung Function and Nutritional Outcomes in Cystic Fibrosis
Gary L. McPhail | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-5/W11-5A: Abstract 372. Effect of Key Phamacological Therapies on Decline in Lung Function in Adults with Cystic Fibrosis
Paul M. Beringer | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-6/W11-6A: Abstract 373. Evaluation of a Pulmonary Exacerbation Score in Adults with Cystic Fibrosis
Nathan C. Kraynack | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W11-7/W11-7A: Discussion & Wrap-up
Nathan C. Kraynack | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W12/W12A: CFTR Structure & Protein Interactions | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-0/W12-0A: Introduction
Patrick Thibodeau | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-1/W12-1A: Abstract 7. PKC Phosphorylation Is Necessary for PKA-dependent Binding of the Domain with the Rest of CFTR
Valerie Chappe | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-2/W12-2A: Abstract 8. Cooperative Domain Assembly Is Essential for CFTR Folding in Living Cells
Gergely L. Lukacs | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-2B/W12-2BA: Abstract 10. Interactions with Nascent CFTR as it Exits the Ribosome
Andrey Karamyshev | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-3/W12-3A: Relationships Between CFTR Domain Folding and Chloride Channel Activation
Eric J. Sorscher | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-4/W12-4A: Abstract 11. ATP Occlusion at the First Nucleotide Binding Domain (NBD1) of CFTR Is Independent of the Second (NBD2) and Therefore of NBD Dimerization
Luba Aleksandrov | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-5/W12-5A: Abstract 12. CFTR Structure: What Can We Learn from Electron Microscopy?
Robert Ford | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W12-6/W12-6A: Discussion & Wrap-up
Robert Ford, Patrick Thibodeau | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W13/W13A: Biomarkers of Airway Physiology & Host Defense | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-0/W13-0A: Introduction
Steven M. Rowe | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-1/W13-1A: Abstract 80. Standardization of Mucociliary and Cough Clearance Methodology
William Bennett | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-2/W13-2A: Abstract 81. Assessment of Induced Sputum as a Tool to Evaluate Anti-inflammatory Agents in CF
James F. Chmiel | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-3/W13-3A: Abstract 82. UK CF Gene Therapy Consortium Tracking Study: Change in Sputum Properties in Response to IV Antibiotic
Uta Griesenbach | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-4/W13-4A: Abstract 83. A Novel Proteolytically-derived Neutrophil Chemoattractant in Cystic Fibrosis: Role as Biomarker and Possible Therapeutic Target
Amit Gaggar | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-5/W13-5A: Abstract 84. Novel Mediators of Persistent Neutrophilic Inflammation in Cystic Fibrosis
Steven M. Rowe | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-6/W13-6A: Abstract 85. A Simple and Non-invasive Method to Assess CF Airways Inflammation: Mass Spectrometric Detection of Purines and Urea in Exhaled Breath Condensate
Charles Esther | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W13-7/W13-7A: Discussion & Wrap-up
James F. Chmiel | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W14/W14A: Ion Transport & Mucosal Function | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-0/W14-0A: Introduction
Lane L. Clarke | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-1/W14-1A: Abstract 86. Chloride-bicarbonate Exchange in Human Bronchial Epithelial (HBE) Cells Treated with Interleukin 17A (IL-17A)
James L. Kreindler | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-2/W14-2A: Abstract 87. Activation of Nasal Epithelial CLC-2 Channels Rescues Chloride Transport in Cystic Fibrosis Mice
Kelvin D. MacDonald | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-3/W14-3A: Abstract 88. Adenosine-mediated Regulation of CFTR and ASL Homeostasis Requires an Intact Cytoskeleton
Lucy Chambers | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-4/W14-4A: Abstract 89. Dynamics of Liquid Secretion Responses of Porcine Tracheal Submucosal Glands to Acetylcholine and VIP
Stephen T. Ballard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-5/W14-5A: Abstract 92. Protease Inhibitor Regulation of ENaC Function in the Airway: From in vitro to in vivo
Henry Danahay | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-6/W14-6A: Abstract 93. Serca Pump Inhibitors Reduce Amiloride-sensitive Sodium Absorption and ENaC Expression
Calvin Cotton | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W14-7/W14-7A: Discussion & Wrap-up
Sherif E. Gabriel | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W15/W15A: Microbial Diversity & Ecology of CF Airways | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-0/W15-0A: Introduction
Susan V. Lynch | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-1/W15-1A: Abstract 311. Detection of Anaerobic Bacteria in Sputum from Cystic Fibrosis Patients with an Acute Pulmonary Exacerbation
Michael M. Tunney | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-2/W15-2A: Abstract 312. Molecular Identification of Bacteria in the CF Airway
Kirk J. Harris | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-3/W15-3A: Abstract 313. Microbial Community Analysis of CF Sputum Using the Novel 16S rRNA
Susan V. Lynch | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-4/W15-4A: Analysis of the Lung Bacterial Communities Present in Patients at Two Cystic Fibrosis Centers in America and Britain
Kenneth D. Bruce | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-5/W15-5A: Abstract 314. The P. aeruginosa Burden of the CF Lung - Uncovering the Black Box
Thomas Bjarnsholt | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-6/W15-6A: Abstract 315. PCR Diagnosis of Respiratory Viruses in Children with Cystic Fibrosis
Jane L. Burns | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W15-7/W15-7A: Discussion & Wrap-up
Matthew C. Wolfgang | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W16/W16A: Increasing Social Support & Information Exchange Among Patients & Families | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-0/W16-0A: Introduction
Patricia D. Mendoza | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-1/W16-1A: Abstract 550. Perceived Social Support for Caregivers of Children with Cystic Fibrosis
David Barker | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-2/W16-2A: What Do Parents of Children with CF Want and Need Regarding Emotional and Spiritual Support from Their Healthcare Teams?
Michelli Gomez-Knowlton | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-3/W16-3A: Abstract 551. Evaluation of a Community Youth Befriending Service for Young People with CF
Kath MacDonald | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-4/W16-4A: Thank You for Caring, But Don't Tell Me What to Do: Adolescent Perspectives on Social Support from Peers, Family, and Healthcare Teams
Kimberly A. Driscoll | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-5/W16-5A: Abstract 552. Young Adults without Family Support - How Can We Help?
Beth Sufian | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-6/W16-6A: Abstract 553. A DVD Presentation - An Adult Cystic Fibrosis Couples Support Group: Reducing Isolation while Living with Life-threatening Illness
Damien Wilson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W16-7/W16-7A: Discussion & Wrap-up
Avani C. Modi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W17/W17A: QI - Lessons Learned | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-0/W17-0A: Introduction
Mary M. Kontos | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-1/W17-1A: Abstract 463. Improving Evidenced Based Awareness and Practitioner Use of CF Pulmonary Medications
Jeanne Weiland | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-2/W17-2A: Abstract 464. Optimizing Lung Function in People with Cystic Fibrosis Through Consistent and Aggressive Identification and Treatment of Pulmonary Exacerbations
Jalayne Lapke | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-3/W17-3A: Abstract 465. The Impact of Re-education of Airway Clearance Techniques (REACT) on Adherence and Pulmonary Function in Patients with Cystic Fibrosis
Robert Zanni | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-4/W17-4A: Abstract 466. Maintain the Gain: Application of Continuous Quality Improvement to Nutritional Cystic Fibrosis Care
Julissa Corredor-Buchmann | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-5/W17-5A: Abstract 467. Project 4 or More: Improving Clinic Attendance to Four or More Times a Year at Arkansas Children's Hospital Cystic Fibrosis Care Center
Lauren Willis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-6/W17-6A: Abstract 468. Evaluation of Northeastern Ontario's Clinic Round Table Format
Joanne Tramontini | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W17-7/W17-7A: Discussion & Wrap-up
Stacy L. VandenBranden | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W18/W18A: Infection Control | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-0/W18-0A: Introduction
Diane M. Kitch | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-1/W18-1A: Abstract 317. Epidemiology of Anterior Nares Colonization with Staphylococcus aereus in Children with CF and Their Household Members
Anne Stone | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-2/W18-2A: Abstract 318. Implementation of an Eradication Protocol and Revision of Infection Control Guidelines to Reduce MRSA Rates in Pediatric Patients with Cystic Fibrosis
Amy DeLaney | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-3/W18-3A: Abstract 319. Effectiveness of Alcohol-based Cleansers During CF Clinic Visits in Reducing Patient Hand Contamination by Respiratory Pathogens
Jonathan B. Zuckerman | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-4/W18-4A: A Practical Approach to Infection Control
Cristine Mavaro | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-5/W18-5A: Barriers to Adherence to Infection Control as Experienced by Healthcare Professionals Compared with CF Patients and Their Families
Elizabeth Garber | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-6/W18-6A: Infection Control or Social Control: The Psychosocial Impact on CF Patient and Their Families
Melissa McClure | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W18-7/W18-7A: Discussion & Wrap-up
Paula H. Lomas | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W19/W19A: GI, Liver, & Nutrition Research | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-0/W19-0A: Introduction
Sarah Jane Schwarzenberg | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-0/W19-0A: Abstract 486. Treatment with Ursodeoxycholic Acid, But Not with Cholic Acid Increases Bile Flow Independently of Cystic Fibrosis Transmembrane Regulator in Mice
Frank Bodewes | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-2/W19-2A: Abstract 487. Ursodeoxycholic Acid (UCDA) Therapy in a Congenic CF-Mouse Model of Liver Disease
Satti Beharry | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-3/W19-3A: Abstract 488. Altered Eicosanoid Metabolism in the CF Mouse Small Intestine
Robert DeLisle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-4/W19-4A: Abstract 489. Reproducibility of the Malabsorption Blood Test (MBT)
Maria Mascarenhas | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-5/W19-5A: Abstract 490. Immunomodulatory Properties of Vitamin D in Scandinavian Cystic Fibrosis Patients
Terezia Pincikova | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-6/W19-6A: Abstract 491. Anemia Is a Serious Comorbid Condition in Cystic Fibrosis and Is Associated with Poor Lung Function
Annette von Drygalski | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W19-7/W19-7A: Discussion & Wrap-up
Jean L. Tomezsko | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W20/W20A: Multi-disciplinary Update on Lung Transplant: Pre & Post Care | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-0/W20-0A: Introduction
Albert Faro | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-1/W20-1A: Nutritional Considerations Pre and Post Lung Transplant
Daina B. Kalnins | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-2/W20-2A: Abstract 420. CT Scans from CF Patients Screened for Lung Transplant: The Severe Advanced Lung Disease (SALD) CT Scoring System and Correlation with Survival: Preliminary Results
Martine Loeve | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-3/W20-3A: Fit for Transplant: Physiotherapy Issues and Optimisation
Penelope Agent | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-4/W20-4A: Abstract 421. A Prospective Randomized Trial Comparing Airway Clearance Strategies Following Lung Transplantation
Prue E. Munro | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-5/W20-5A: Abstract 423. Cystic Fibrosis Quality of Life Comparison Between Male vs. Female Pediatric Lung Transplant Recipients
Marlyn S. Woo | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-6/W20-6A: Abstract 424. Lack of Progression of Liver Disease in CF Patients Following Lung Transplantation - Evidence that Lung Transplantation Is Safe in this Group of Patients
Edward Nash | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W20-7/W20-7A: Discussion & Wrap-up
Penelope Agent | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
P3/P3A: Improving Patient Outcomes Using the Tools We Have Now
Michael P. Boyle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
P3-0/P3-0A: Plenary Session III: "Improving Patient Outcomes Using the Tools We Have Now"
Michael P. Boyle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S15/S15A: Regulation of Airway Surface Liquid | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S15-0/S15-0A: Introduction
John W. Hanrahan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S15-1/S15-1A: Aquaporins and Their Role in ASL Volume Homeostasis
Ramana Sidhaye | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S15-2/S15-2A: Regulation of Airway ENaCs by Proteases: An Increasingly Complex Story
Michael M. Myerburg | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S15-3/S15-3A: Control of CFTR-mediated ASL Secretion by Adenosine and ENaC
Robert Tarran | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S15-4/S15-4A: Airway Surface Liquid pH and Innate Defense by the NADPH Oxidase
Horst Fischer | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S16/S16A: Outcome Measures to Assess CF Interventions | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S16-0/S16-0A: Introduction
Bonnie W. Ramsey | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S16-1/S16-1A: Invasive and Non-invasive Markers of Airway Inflammation
Jane Davies | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S16-2/S16-2A: Measures of CFTR Molecular and Clinical Function
Eric Alton | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S16-3/S16-3A: Lower Airway Markers of Infection and Inflammation
Claire E. Wainwright | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S16-4/S16-4A: Measures of Mucociliary Clearance in Assessment of New CF Therapies
Scott H. Donaldson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S17/S17A: The Inflammatory Process in CF: A Complex Picture with Many Players | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S17-0/S17-0A: Introduction
Carlos E. Milla | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S17-1/S17-1A: Revisiting the Role of CFTR Deficiency in Promoting Inflammation
Pamela B. Davis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S17-2/S17-2A: Cytokines of the Innate and Adaptive Immune System in CF Lung Inflammation
Jay Kolls | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S17-3/S17-3A: A Unifying Theory to Explain How CFTR Leads to the Lipid Abnormalities in CF and Altered Inflammatory Signaling
Steven D. Freedman | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S17-4/S17-4A: A Real-life View of Inflammation in CF: Novel Functional Assays for Immune Cell Analysis
Rabindra M. Tirouvanziam | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S18/S18A: Bone Disease: Pathophysiology & Measurements | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S18-0/S18-0A: Introduction
Sarah Elkin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S18-1/S18-1A: Pediatric Bone Health: Starting at the Beginning
Isabelle Sermet-Gaudelus | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S18-2/S18-2A: CF Bone Disease: Is Mutant CFTR Really the Culprit?
Gregory Clines | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S18-3/S18-3A: The Value of High-dose Cholecalciferol Supplementation to Replenish Vitamin D in CF
Anne Stephenson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S18-4/S18-4A: The Influence of Pulmonary Infection on Bone Metabolism in Cystic Fibrosis
Charles Haworth | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S19/S19A: Clinical Infectious Diseases | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S19-0/S19-0A: Introduction
Andrew M. Jones | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S19-1/S19-1A: Impact of MRSA on Clinical Status in CF
Michael Schwartz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S19-2/S19-2A: Current Antibiotic Resistance Patterns in CF
Jane Burns | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S19-3/S19-3A: New Antibiotic Strategies for Treating Pulmonary Infection with Pseudomonas aeruginosa
Alan Smyth | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S19-4/S19-4A: The Challenge of Emerging Pathogens in CF
John J. LiPuma | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| S20/S20A: Herding Cats: Coordinating CF Care Today | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S20-0/S20-0A: Introduction
Cindy Capen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S20-1/S20-1A: Living with the Complicated CF Patient: A Parent's Perspective
Laura Farach | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S20-2/S20-2A: Juggling, Balancing and Other Circus Acts: Orchestrating Pediatric CF Care
Mary M. Kontos | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S20-3/S20-3A: Coordinating of Care and the Pursuit of Infection Control
Anna O. Tsang | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
S20-4/S20-4A: Research Coordination: How Does it Fit Into the Big Picture?
Deborah A. Ouellette | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W21/W21A: Newborn Screening & Genetics | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-0/W21-0A: Introduction
Marci K. Sontag | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-1/W21-1A: Abstract 189. An Improved Newborn Screening Algorithm in Colorado: IRT/IRT/DNA
Marci K. Sontag | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-2/W21-2A: IRT/Mutation Panel/DNA Sequencing - the California Model for CF Newborn Screening
Martin Kharrazi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-3/W21-3A: Abstract 190. Development of a DNA-based Cystic Fibrosis Newborn Screening Proficiency Testing Program
Marie Earley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-4/W21-4A: Borderline Sweat Tests in CF Newborn Screening - Diagnostic Dilemmas and Long Term Follow-up
Richard B. Parad | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-5/W21-5A: Abstract 191. Adolescents and Young Adults with CF: Knowledge of the Genetic Basis of CF and Their Reproductive Risks
Grace Houser | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-6/W21-6A: Abstract 192. Patient Assessment of Genetic Counseling and Cystic Fibrosis Newborn Screening Program at the University of Minnesota Medical Center, Fairview
Amy Powers | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W21-7/W21-7A: Discussion & Wrap-up
Marci K. Sontag | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W22/W22A: Molecular Mechanisms for CFTR Correction & Potentiation | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-0/W22-0A: Introduction
David Clarke | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-1/W22-1A: Abstract 243. Correction of ?F508 CFTR Trafficking Defect by a Novel Family of Marine Sponge Derived Alkaloids
Graeme W. Carlile | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-2/W22-2A: Abstract 244. Rescuing ?F508-CFTR Retention with CFTR Derived Peptides Containing the Di-basic RXR Motif (CF-RXR)
Patrick Kim Chiaw | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-3/W22-3A: Abstract 245. Small Molecular Correctors Increase the Surface Stability of Rescued ?F508 CFTR
Karoly Varga | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-4/W22-4A: Abstract 246. Design and Synthesis of a Hybrid Potentiator-corrector Agonist of ?F508-CFTR
Aaron Mills | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-5/W22-5A: Abstract 247. N6-(2-Phenylethyl)-ATP Potentiates G551D-CFTR by Binding to the Hydrolysis-incompetent Site (NBD1)
Silvia Bompadre | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-6/W22-6A: Abstract 248. VX-770, A Potent, Selective, and Orally Bioavailable Potentiator of CFTR Gating
Fredrick van Goor | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W22-7/W22-7A: Discussion & Wrap-up
David N. Sheppard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W23/W23A: Airways Epithelial Biology | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-0/W23-0A: Introduction
Nam Soo Joo | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-1/W23-1A: Abstract 94. Differential Expression of Sarcoendoplasmic Reticulum Calcium Atpases (Sercas) in Cystic Fibrosis (CF) Epithelium
Shama Ahmad | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-2/W23-2A: Abstract 95. Evaluation of the SCN-/H2O2/Lactoperoxidase System as an Antibacterial Defense in Human Airway Epithelium
Elvira Sondo | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-3/W23-3A: Abstract 96. Flagellin Activates P38, PI3 Kinase, NF-KB and CFTR-dependent Cl Secretion in Airway Gland Epithelial Cells
Terry E. Machen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-4/W23-4A: Abstract 97. Hypertonic Challenge Inhibits Sodium Transport in Human Bronchial Epithelial Cells
Hector Rasgado-Flores | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-5/W23-5A: Abstract 98. The Soluble Protein Plunc Regulates ENaC in Human Bronchial Cell Cultures
Erol Gaillard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-6/W23-6A: Abstract 99. Prostasin Expression Is Regulated by Airway Surface Liquid Volume and Is Increased in Cystic Fibrosis
Michael M. Myerburg | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W23-7/W23-7A: Discussion & Wrap-up
Brian Button | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W24/W24A: National/International CF Registries & QI | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-0/W24-0A: Introduction
Mary Corey | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-1/W24-1A: Public Reporting of Cystic Fibrosis Outcomes: Methods for Case-Mix Adjustment
Hebe Quinton | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-2/W24-2A: Abstract 447. A Patient and Family Survey to Collect the Socioeconomic Variables in the Cystic Fibrosis Foundation Patient Registry: Methods and Results
Susanna A. McColley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-3/W24-3A: Abstract 448. Trends in CF Respiratory Microbiology in the U.S., 1995-2005
Samiya Razvi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-4/W24-4A: Abstract 449. Multi-slope Models of Lung Disease as an Alternative to Single Slope Models
Annalisa VanderWyden | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-5/W24-5A: Abstract 450. Predictors of Hospitalization in Cystic Fibrosis: Is There a Gender Gap?
Anne Stephenson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-6/W24-6A: European Registry
Gita Mehta | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W24-7/W24-7A: Discussion & Wrap-up
Gerald T. O'Connor | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W25/W25A: Interactions of Pathogens & the CF Host | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-0/W25-0A: Introduction
Daniel J. Wozniak | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-1/W25-1A: Abstract 320. Persistent Nontypeable Haemophilus influenzae Infection Induces Airway Epithelial Tolerance to Pseudomonas aeruginosa
Timothy D. Starner | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-2/W25-2A: Abstract 321. Human Airway Epithelial Cells Facilitate Biofilm Formation by Pseudomonas aeruginosa
Sophie Moreau-Marquis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-3/W25-3A: Abstract 322. The Pseudomonas aeruginosa Biofilm Matrix: A Mannose- and Galactose-rich Exopolysaccharide Is Anchored in a Helical Pattern on the Cell Surface and Acts as an Extracellular Scaffold Holding Biofilm Cells Together
Luyan Ma | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-4/W25-4A: Abstract 323. Pseudomonas aeruginosa Induces Rapid Necrotic Killing of PMNs by Quorum Sensing-controlled Production of Rhamnolipid
Peter O. Jensen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-5/W25-5A: Abstract 324. Pseudomonas aeruginosa in Cystic Fibrosis: Pyocyanin Negative Strains Are Associated with BPI-ANCA and Progressive Lung Disease
Malin Carlsson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-6/W25-6A: Abstract 325. Pseudomonas aeruginosa Type III Secretion and Lung Function Decline in Cystic Fibrosis
Susanna A. McColley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W25-7/W25-7A: Discussion & Wrap-up
Barbara Kazmierczak | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W26/W26A: Models of Palliative Care | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W26-0/W26-0A: Introduction
Laura Sollenberger | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W26-1/W26-1A: End of Life: The Importance of Family-centered Care
Mary Jo Chambers | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W26-2/W26-2A: Advance Directives: Interventions at Emory
Pat Tatro | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W26-3/W26-3A: Abstract 554. Advance Care Planning in Adults with CF
Gregory Sawicki | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W26-4/W26-4A: End of Life Discussion: Is There Still Hope
Kathryn Moffett | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W26-5/W26-5A: Developing a Palliative Care Approach to CF
Katherine Reed | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W26-6/W26-6A: Discussion & Wrap-up
Annie C. McCauley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W27/W27A: Patient-Family Centered Care | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W27-0/W27-0A: Introduction
Judy Hollingsworth | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W27-1/W27-1A: Abstract 572. Improving Team Communication on the Inpatient Pulmonary Unit
Jean Anne Cieplinski-Robertson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W27-2/W27-2A: Teaching the Newly Diagnosed Adult: Using a Creative Approach
Anna Tsang | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W27-3/W27-3A: Strengthening Partnerships by Engaging Families as Members of the CF Team
Christine Culp Gonzalez | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W27-4/W27-4A: Passport for Teens: Helping Families Facilitate Transition
Miriam Kaufman | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W27-5/W27-5A: Teaching Day for Teens
Louise T. Taylor | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W27-6/W27-6A: Discussion & Wrap-up
Louise T. Taylor | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W28/W28A: Parenting Challenges & Parent Stress: Overcoming Barriers to Adherence to Treatments | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-0/W28-0A: Introduction
Scott W. Powers | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-1/W28-1A: Abstract 555. Effects of Caregiver Depression on Self-reported and Electronically Monitored Enzyme Adherence and Short-term Changes in Weight for Children with CF
Alexandra L. Quittner | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-2/W28-2A: Abstract 556. Challenges of Living with Cystic Fibrosis (CLCF): Psychometric Evaluation of a New Measure
Claire Glasscoe | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-3/W28-3A: Abstract 557. Effects of Behavioral-family Systems Therapy on Family Conflict and Communication in Adolescents with CF and Their Parents
Ivette Cruz | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-4/W28-4A: Bridging the Gap Between Research and Application: Provider and Parent Perspectives
Suzanne H. Michel | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-5/W28-5A: Helping Families of Young Children Meet Care Goals: Case Presentations
Scott W. Powers | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-6/W28-6A: Helping the Families of School-age Children Meet Care Goals: Case Presentations
Lori J. Stark | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W28-7/W28-7A: Discussion & Wrap-up
Scott W. Powers | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W29/W29A: Fatty Acids & Inflammation: Alterations in Uptake & Metabolism of Fatty Acids in CF | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W29-0/W29-0A: Introduction
Brian O'Sullivan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W29-1/W29-1A: Introduction to Fatty Acid Metabolism
Michael Laposata | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W29-2/W29-2A: Abstract 492. Increased Metabolism of Linoleic Acid Through the N-6 Pathway in Cultured Cells with a Cystic Fibrosis Phenotype Is Corrected by Docosahexaenoic Acid (DHA) Supplementation
M. Rabie AL-Turkmani | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W29-3/W29-3A: Abstract 494. Impaired PPAR? Regulation as a Key Player in CF Fatty Acid Imbalance
Aura Perez | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W29-4/W29-4A: Abstract 495. Decreased PEMT Activity in CF Mice Is Dependent on Cholin Status
Munir M. Zaman | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W29-5/W29-5A: Abstract 496. Type of Dietary Fat Intake to Serum Fatty Acid Status in Children with CF
Asim Maqbool | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W29-6/W29-6A: Discussion & Wrap-up
Brian O'Sullivan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| W30/W30A: Physical Activity & Exercise in CF - What Are the Outcomes? | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-0/W30-0A: Introduction
David M. Orenstein | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-1/W30-1A: Abstract 436. Effects of Different Conditioning Programs on Quality of Life in CF
Helge Hebestreit | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-2/W30-2A: Abstract 437. Effects of an Exercise Program on Motor Performance in Preschool Children with CF
Wolfgang Gruber | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-3/W30-3A: Abstract 438. Motor Performance in Preschool Children with CF Compared to Healthy Children
Wolfgang Gruber | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-4/W30-4A: Abstract 439. Reliability and Validity of the Habitual Activity Estimation Scale (HAES) in Patients with Cystic Fibrosis
Greg D. Wells | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-5/W30-5A: Abstract 440. Long-term Effect of Habitual Physical Activity on Lung Health in Patients with Cystic Fibrosis
Donna L. Wilkes | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-6/W30-6A: Abstract 441. Development of an Exercise Knowledge Test for Children with Cystic Fibrosis
Linda W. Higgins | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
W30-7/W30-7A: Discussion & Wrap-up
Matthew Nippins | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC1/SC1A: Drug Treatment Options in CF Care: Beyond the Basics | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC1-0/SC1-0A: Antimicrobial Therapy in Cystic Fibrosis - Beyond the Basics
Robert J. Kuhn | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC1-1/SC1-1A: Use of Antibiotics in Difficult to Manage CF Patients
Robert J. Kuhn | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC1-2/SC1-2A: Treatment and Prevention of early P. aeruginosa infection
Felix Ratjen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC1-3/SC1-3A: MRSA Infection in Cystic Fibrosis
Michael I. Anstead | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC1-4/SC1-4A: Optimizing Management of Pulmonary Exacerbation in Cystic Fibrosis
Elizabeth Tullis | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC2/SC2A: CF Basic Science for the Clinician | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC2-0/SC2-0A: Introduction
Mauri E. Krouse | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC2-1/SC2-1A: CFTR: Gene to Protein - How Mutations in CFTR Lead to Cystic Fibrosis A Basic Scientist's View
Lynda S. Ostedgaard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC2-2/SC2-2A: How does CFTR work as a chloride channel, and how do we study its function?
Tzyh-Chang Hwang | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC2-3/SC2-3A: CF Lung Disease
Mauri E. Krouse | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC2-4/SC2-4A: Therapy for Cystic Fibrosis Based on a Rational Understanding of CFTR
David N. Sheppard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC3/SC3A: Advanced Motivational Interviewing & CF: A Practical Workshop for Teams | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-0/SC3-0A: Introductions
Gary J. Latchford | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-1/SC3-1A: Adherence & the therapeutic relationship
Alistair J.A. Duff | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-10/SC3-10A: The Next Step
Mary W. Moore | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-2/SC3-2A: Motivational Interviewing REFRESHER
Alistair J.A. Duff | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-3/SC3-3A: Expressing empathy
Kristin A. Riekert | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-4/SC3-4A: Rolling With Resistance
Alistair J.A. Duff | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-5/SC3-5A: Change & Supporting Self-Efficacy
Mary W. Moore | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-6/SC3-6A: MI in practice
Mary W. Moore | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-7/SC3-7A: Information Exchange
Alistair J.A. Duff | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-8/SC3-8A: Non Diirective Skills
Alistair J.A. Duff | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC3-9/SC3-9A: Signs of Resistance
Kristin A. Riekert, Alistair J.A. Duff | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC4/SC4A: Quality Improvement in CF Care: Steal Shamelessly, Share Generously | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-0/SC4-0A: CF Strategic QI Initiative
Bruce C. Marshall | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-1/SC4-1A: Overview of Clinical Microsystems Thinking
Gene Nelson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-2/SC4-2A: Getting Started with the Fundamentals
Christine M. Singh | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-3/SC4-3A: Diagnosis, Improvement Ramp, Aims, FlowchartsCase
Meghan Podliska, Gene Nelson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-4/SC4-4A: Change Concepts, PDSA-SDSA
Gene Nelson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-5/SC4-5A: Smart Change Ideas & Pulmonary Case
Nathan C. Kraynack | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-6/SC4-6A: Nutrition Case
Cathy M. Lingard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-7/SC4-7A: Engaging Patients and Families
Leslie Hazle | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC4-8/SC4-8A: Discussion and Wrap Up
Marjorie M. Godfrey | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC5/SC5A: Implementation of CF Newborn Screening & Current Approaches to Evaluation & Treatment | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-0/SC5-0A: Introduction
Michael J. Rock | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-1/SC5-1A: Experience with the Rubric in Washington State
Margaret Rosenfeld | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-2/SC5-2A: Experience with the Rubric: California
Martin Kharrazi | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-3/SC5-3A: Experience with the Rubric: Challenges in Utah
Barbara A. Chatfield | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-4/SC5-4A: Completing the communications circle for QA
Anne M. Comeau | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-5/SC5-5A: Family focus after the initial diagnosis
Darci Pfeil | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-6/SC5-6A: Malnutrition: Prevention and Treatment
Jack K. Sharp | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC5-7/SC5-7A: Lung Disease: Prevention and Treatment
Scott D. Sagel | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC5-8/SC5-8A: SC5.8 TBD | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC6/SC6A: Challenges & Goals for Clinical Research Practice Management | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC6-0/SC6-0A: Introduction
Lois A. Brass | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC6-1/SC6-1A: The Why, What, and When of SOPs
Elizabeth Hartigan | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC6-2/SC6-2A: Best Practices for Study Implementation
Jill Van Dalfsen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC6-3/SC6-3A: Tools for Efficiency
Elizabeth Hartigan, Jill Van Dalfsen | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC6-4/SC6-4A: Leadership/Management Balance
Joseph Price | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC7/SC7A: Pulmonary Pathophysiology & Pharmacology for Advanced Practice Nurses | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC7-1/SC7-1A: Cystic Fibrosis Lung Disease: pathophysiology, disease complications, and treatment
Susanna McColley | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC7-2/SC7-2A: Pulmonary Function Testing in CF: Infant to Adult
Carlos E. Milla | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC7-3/SC7-3A: Pulmonary Pharmacology in Cystic Fibrosis
Antoinette Gardner | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC7-4/SC7-4A: Use & Interpretation of Different Radiology Techniques in Assessing Pulmonary Status in Patients with Cystic Fibrosis
Terry Robinson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC7-5/SC7-5A: Beyond the Physical - a Holistic Approach to Care
Mary Jo McCracken | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC7-6/SC7-6A: Questions
Susanna McColley, Mary Jo McCracken, Antoinette Gardner, Terry Robinson | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC8/SC8A: Basic ACT for the CF Team | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-0/SC8-0A: Introduction
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-1/SC8-1A: Active Cycle of Breathing
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-2/SC8-2A: Autogenic Drainage
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-3/SC8-3A: Positive Expiratory Pressure
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-4/SC8-4A: Oscillating PEP
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-5/SC8-5A: High Frequency Chest Wall Oscillation
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-6/SC8-6A: Other Modalities
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-7/SC8-7A: Review of Literature
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-8/SC8-8A: Patient Selection
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC8-9/SC8-9A: Conclusion
Craig D. Lapin, Anne Lapin | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC9/SC9A: CF Nutrition 101 | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-0/SC9-0A: Nutrition for Cystic Fibrosis 101
Karen M. Maguiness | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-1/SC9-1A: Why is nutrition for CF different than nutrition for the general population?
Amanda R. Leonard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-2/SC9-2A: Vitamins and Minerals
Suzanne H. Michel | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-3/SC9-3A: Nutrition in Bone Health in CF
Maria Hanna | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-4/SC9-4A: Pancreatic Enzyme Replacement Therapy
Karen M. Maguiness | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-5/SC9-5A: Newly Diagnosed CF Patient
Terri Schindler | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-6/SC9-6A: Nutrition Assessment - Tube Feedings
Amanda R. Leonard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-7/SC9-7A: Nutrition Management of Cystic Fibrosis Related Diabetes (CFRD)
Carol M. Brunzell | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
| SC9-8/SC9-8A: Nutrition and Port CF | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
SC9-9/SC9-9A: Benchmarking Themes
Amanda R. Leonard | Audio Synchronized to PowerPoint | $ 0.00 | |
| Audio Synchronized to PowerPoint | $ 0.00 | |
If you have any questions, queries or suggestions
regarding our service, please send an email to feedback@cmcgc.com
